Evaluating the HIT Reverse Hip Replacement System for total hip replacement

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to assess the safety and effectiveness of the HIT Reverse Hip Replacement System in patients undergoing total hip arthroplasty (THA). It is a randomized, controlled, multi-center trial involving up to 20 investigational sites. Participants will be divided into two groups: one receiving the investigational device and the other receiving a standard marketed hip replacement system. The study will monitor outcomes related to surgery, post-surgical care, and rehabilitation according to standard practices.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient requires primary THA due to NIDJD or any of its composite diagnoses such as osteoarthritis, avascular necrosis, posttraumatic arthritis, slipped capital epiphysis, fracture of the pelvis, and diastrophic variant requiring unilateral primary THA.
* Patient is between 50 (inclusive) and 75 (inclusive) years of age at the time of enrollment.
* Patient has preoperative medical clearance and is free from or treated for medical conditions that would pose excessive operative risk.
* Patient has a signed and dated Informed Consent Form (ICF).
* Patient is willing and able to participate in required follow-up visits at the investigational site and to complete study procedures and questionnaires.

Exclusion Criteria:

* Patient has received earlier THA, hemi-arthroplasty, or fusion in the contralateral hip in the last 24 months.
* Patient has received earlier THA, hemi-arthroplasty, or fusion in the contralateral hip more than 24 months ago and has a contralateral hip-specific pain rating of ≥2 on a Numeric Rating Scale 0-10.
* Patient needs bilateral hip replacement or has a planned THA on the contralateral hip joint in the next 24 months.
* Patient needs knee arthroplasty or has a planned total knee arthroplasty in the next 24 months.
* Patient has a known allergy to titanium and/or XLPE.
* Patient has known metal sensitivities to cobalt chromium (CoCr).
* Patient has a history of septic arthritis in the index joint.
* Patient has insufficient acetabular or femoral bone stock in which good anchorage of the implants is unlikely or impossible.
* Patient has total or partial absence of the muscular or ligamentous apparatus.
* Patient has known moderate to severe renal insufficiency.
* Patient has vascular insufficiency, muscular atrophy, or neuromuscular disease in either leg (based on the Investigator's judgment).
* Patient has a deformity of the affected limb or significant anatomic variance of the affected hip.
* Patient has an active malignancy or history of invasive malignancy within the last 5 years, except for superficial basal cell carcinoma or squamous cell carcinoma of the skin that has been definitively treated. Patients with carcinoma in situ of the uterine cervix definitively treated more than 1 year prior to enrollment may enter the study.
* Patient has Paget's disease, Charcot-Marie-Tooth disease, or osteomalacia.
* Patient has an inflammatory DJD including any of its composite diagnoses: rheumatoid arthritis, systemic lupus erythematosus, pigmented villonodular synovitis, juvenile rheumatoid arthritis, and other arthritic processes of inflammatory or autoimmune etiology.
* Patient has any condition that would interfere with self-assessment of pain, function, or quality of life (QoL) required for patient-reported outcomes during the study (based on the Investigator's judgment).
* Patient has a Body Mass Index (BMI) of 40 or higher.
* Patient has an active infection (e.g., hepatitis, Acquired Immune Deficiency Syndrome (AIDS), AIDS-related Complex (ARC)) that is systemic or at the site of the intended surgery.
* Patient is currently participating in any investigational study not related to this study's preoperative or postoperative care.
* Patient is currently pregnant or is planning to become pregnant during the study.
* Patient is a competitive or professional athlete.

Where it's running

• Miami Institute for Joint Reconstruction
  Miami, Florida, United States Recruiting
• Advent Health Hospital, Carrollwood
  Tampa, Florida, United States Recruiting
• Tampa General Health / Florida Orthopedic Institute
  Tampa, Florida, United States Recruiting
• Division of Orthopaedic Surgery
  Somers Point, New Jersey, United States Recruiting
• JIS Orthopedics
  New Albany, Ohio, United States Recruiting
• LifeBridge Health Rubin Institute for Advanced Orthopedics
  Baltimore, Maryland, United States Terminated

Study contacts

• Study coordinator: George Diamantoni
• Email: g.diamantoni@hit-irh.com
• Phone: 1-866-832-4471

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating long-term outcomes of hip hemiarthroplasty surgeries

  This study is trying to see how well hip hemiarthroplasty surgeries using specific implants work and are safe for adults over a long period of up to 10 years.

  Recruiting at 2 sites Corin · Amboise, France and 3 other locations · NCT05686278

• Collarless Actis hip stem for cementless hip replacement in Asian patients

  This study tests how well a collarless Actis hip stem works in adults undergoing primary hip replacement, focusing on outcomes over five years in an East Asian population.

  Recruiting Seoul National University Bundang Hospital · Seongnam-si, Gyeonggi-do · NCT07828080

• Intravenous dexamethasone for better pain control after hip replacement with a PENG block

  This study tests whether giving dexamethasone through a vein, in 0, 4, or 8 mg doses, helps control pain after total hip arthroplasty when used with a PENG block.

  Recruiting Poznan University of Medical Sciences · Poznan · NCT07581470

• Comparing barbed and conventional wound closure after hip or knee replacement

  This study will test whether barbed sutures or conventional sutures lead to better wound healing and fewer complications for adults having primary or aseptic revision hip or knee replacement.

  Recruiting Umraniye Education and Research Hospital · Istanbul, Istanbul · NCT07439575

• Choose to Move Replacement Ready for people waiting for hip or knee replacement

  This project will test whether the Choose to Move Replacement Ready program helps older adults on hip or knee replacement waitlists increase physical activity, improve mobility, and support psychosocial health.

  Recruiting University of British Columbia · Vancouver, British Columbia · NCT07069179

• Evaluating the Zimmer Biomet Shoulder Replacement System

  This study is testing how safe and effective the Zimmer Biomet Shoulder Replacement System is for people getting shoulder surgery, looking at their pain, movement, and quality of life over two years.

  Recruiting at 2 sites Zimmer Biomet · Pforzheim and 1 other locations · NCT06920459

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.